Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1371-1376
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1371
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1371
Figure 1 Hypoxia-inducible factor-1α/angiopoietin-2 pathway in hepatocellular carcinoma progression.
HIF-1α: Hypoxia-inducible factor-1α; VEGF: Vascular endothelial growth factor; Ang-2: Angiopoietin-2; EMT: Epithelial-mesenchymal transition.
- Citation: Du JY, Zhang CT, Li T, Li YP. Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies. World J Hepatol 2024; 16(12): 1371-1376
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1371.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1371